Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.40 |
| ▸ | CA6 | P23280 | 4/20 | 0.40 |
| ▸ | CA7 | P43166 | 4/20 | 0.40 |
| ▸ | CA9 | Q16790 | 4/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.40 |
| ▸ | PAOX | Q6QHF9 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CA4 | P22748 | 3/20 | 0.39 |
| ▸ | CA5A | P35218 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CA3 | P07451 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL29012711 | 1.00 | CA12 (0.40) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL40809 | 0.96 | CA12 (0.43) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL29377459 | 0.96 | CA12 (0.43) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL29220013 | 0.92 | CA12 (0.43) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL11240220 | 0.92 | CA12 (0.43) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL29220017 | 0.92 | CA12 (0.43) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL9759741 | 0.92 | CA12 (0.43) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL11464679 | 0.92 | CA12 (0.43) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL10794096 | 0.92 | CA12 (0.43) | CA12CA6CA7CA9CA14 | |
| Acetic Acid SCHEMBL9815380 | 0.92 | CA12 (0.43) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2575807-B1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | NOVAK MAJA (HR) | 2014-02-19 | — | — | EP | claimed |
| EP-2575807-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | Novak, Maja (HR) | 2013-04-10 | — | — | EP | claimed |
| EP-2575807-B1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | NOVAK MAJA (HR) | 2014-02-19 | — | — | EP | disclosed |
| EP-2575807-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | Novak, Maja (HR) | 2013-04-10 | — | — | EP | disclosed |
| WO-2010097643-A1 | FORMULATION BASED ON MICRONIZED ZEOLITE, GREEN TEA EXTRACT, AND GENISTEIN AS A THERAPEUTIC AGENT FOR REDUCTION OF BODY WEIGHT AND CELLULITE | NOVATECH ISTRAZIVANJE D.O.O. (HR) | 2010-09-02 | — | — | WO | disclosed |
| WO-2010018418-A1 | FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS THERAPEUTIC AGENT PROVIDING HIGHLY BIOAVAILABLE SILICON | NOVATECH D.O.O. (HR) | 2010-02-18 | — | — | WO | disclosed |
| WO-2009133413-A1 | FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS A THERAPEUTIC AGENT FOR REMOVAL OF TOXINS, BACTERIA AND VIRUSES FROM ORGANISM | NOVATECH D.O.O. (HR) | 2009-11-05 | — | — | WO | disclosed |
| EP-0058430-B1 | DYESTUFF-CONTAINING MICROSCOPIC CAPSULE DISPERSION FOR RECORD MATERIALS | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1985-12-04 | — | — | EP | disclosed |
| US-4384871-A | Dyestuff-containing microscopic capsule dispersion for record materials | MITSUI TOATSU CHEMICALS, INC. (JP) | 1983-05-24 | — | — | US | disclosed |
| EP-0058430-A1 | Dyestuff-containing microscopic capsule dispersion for record materials | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1982-08-25 | — | — | EP | disclosed |